Dr. Howard Smith Oncall

Vidcast:  https://www.instagram.com/p/DGyFce9OOpn/GLP-1 receptor agonists—popular for treating diabetes and weight loss—may have additional benefits for the brain. Emerging research suggests these medications could help with addiction, depression, and even cognitive decline.Studies indicate that  GLP-1s may reduce cravings for opioids and alcohol by altering the brain’s reward system, with some trials showing a 40% drop in opioid overdoses and a 50% decrease in alcohol-related hospitalizations. There’s also evidence that these drugs could ease depression by reducing brain inflammation and promoting mood stabilization. Some studies even link them to a lower risk of Alzheimer’s disease, but experts caution that more research is needed before they can be used for dementia treatment.While these findings are promising, researchers urge caution. High costs, limited insurance coverage, and unknown long-term effects mean GLP-1s are not yet a proven solution for psychiatric or neurological conditions.https://www.heali